Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025

1. AVTR reported Q4 sales of $1.69B, missing expectations. 2. Net income surged to $500.4M, up from $98.5M last year. 3. Adjusted EPS was 27 cents, beating the consensus of 26 cents. 4. Guidance indicates 2025 revenue growth of 1%-3% after a 2024 decline. 5. Stock dipped 3.73% at $20.89 in premarket trading.